TrialAmerican journal of hematology2024

Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.

Annie Im et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.